Holen Sie sich die Stockscreener-App
87.69
0.93%
0.81
Handel nachbörslich:
87.69
Nuvalent Inc Aktie (NUVL) Neueste Nachrichten
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely - Simply Wall St
FY2024 EPS Estimates for Nuvalent Reduced by Leerink Partnrs - MarketBeat
What is Wedbush's Forecast for Nuvalent FY2024 Earnings? - MarketBeat
Perceptive Advisors LLC Expands Stake in Nuvalent Inc - GuruFocus.com
Paradigm Biocapital Advisors LP Acquires Significant Stake in Nu - GuruFocus.com
State of New Jersey Common Pension Fund D Makes New $2.41 Million Investment in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
How to Take Advantage of moves in (NUVL) - Stock Traders Daily
Nuvalent (NASDAQ:NUVL) Announces Quarterly Earnings Results - MarketBeat
Nuvalent (NASDAQ:NUVL) Stock Price Expected to Rise, BMO Capital Markets Analyst Says - MarketBeat
Nuvalent Reports Q3 2024 Progress and Financials - TipRanks
Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results - The Malaysian Reserve
Nuvalent Secures $1.2B Cash Runway Through 2028, Reports Strong Trial Progress | NUVL Stock News - StockTitan
Nuvalent Inc. (NUVL) Quarterly 10-Q Report - Quartz
Crescent Biopharma Appoints Susan Moran, MD, MSCE, and Alexandra Balcom, MBA, CPA, to Board of Directors - The Malaysian Reserve
Nuvalent Appoints Chief Scientific Officer - Contract Pharma
AlphaCentric Advisors LLC Invests $716,000 in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent CFO Alexandra Balcom sells $891,879 in stock By Investing.com - Investing.com Canada
Nuvalent CFO Alexandra Balcom sells $891,879 in stock - Investing.com
Nuvalent's chief development officer Noci Darlene sells $442,980 in shares - Investing.com
Nuvalent's chief development officer Noci Darlene sells $442,980 in shares By Investing.com - Investing.com Australia
Nuvalent, Inc. (NASDAQ:NUVL) CFO Alexandra Balcom Sells 10,000 Shares - MarketBeat
abrdn plc Sells 40,233 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
(NUVL) Technical Data - Stock Traders Daily
Nuvalent, Inc. (NASDAQ:NUVL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Z - GuruFocus.com
Oversold Conditions For Nuvalent (NUVL) - Nasdaq
Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Sci - GuruFocus.com
PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update - StockTitan
Nuvalent to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GuruFocus.com
UBS Initiates Coverage of Nuvalent (NUVL) with Neutral Recommendation - MSN
Nuvalent, Inc. (NASDAQ:NUVL) Director Sells $195,500,000.00 in Stock - MarketBeat
Nuvalent sees $195.5 million stock sale by Deerfield Management - Investing.com
Nuvalent (NASDAQ:NUVL) Earns Neutral Rating from Analysts at UBS Group - MarketBeat
Where are the Opportunities in (NUVL) - Stock Traders Daily
Nuvalent (NASDAQ:NUVL) Shares Gap DownShould You Sell? - MarketBeat
Nuvalent 2M share Spot Secondary priced at $99.00 - TipRanks
Nuvalent CEO Porter sells shares worth $2.76 million - Investing.com
Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) CEO Sells 27,000 Shares of Stock - MarketBeat
Nuvalent CEO Porter sells shares worth $2.76 million By Investing.com - Investing.com UK
AQR Capital Management LLC Has $1.01 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
AQR Capital Management LLC Sells 8,783 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
The Attractiveness of Investing In Nuvalent Inc (NUVL) is Growing - Knox Daily
Financial Metrics Unveiled: Nuvalent Inc (NUVL)’s Key Ratios in the Spotlight - The Dwinnex
Nuvalent, Inc. (NASDAQ:NUVL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
NVL-655 overcomes ALK inhibitor limitations - BioWorld Online
JPMorgan Chase & Co. Boosts Nuvalent (NASDAQ:NUVL) Price Target to $125.00 - MarketBeat
Nuvalent executive sells over $500k in stock, buys $94.6k By Investing.com - Investing.com Australia
Nuvalent, Inc. (NASDAQ:NUVL) Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
Nuvalent executive sells over $500k in stock, buys $94.6k - Investing.com
Nuvalent CFO Alexandra Balcom sells shares worth over $1 million By Investing.com - Investing.com Canada
Nuvalent CFO Alexandra Balcom sells shares worth over $1 million - Investing.com
Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells $508,700.00 in Stock - MarketBeat
Was there any good news for Nuvalent Inc (NUVL) stock in the last session? - US Post News
(NUVL) Long Term Investment Analysis - Stock Traders Daily
Marshall Wace LLP Buys 77,229 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent's SWOT analysis: promising cancer drug stock faces pivotal year - Investing.com India
Perceptive Advisors LLC Sells 234,377 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent's SWOT analysis: promising cancer drug stock faces pivotal year By Investing.com - Investing.com UK
D. E. Shaw & Co. Inc. Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):